![Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome | Scientific Reports Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-87098-x/MediaObjects/41598_2021_87098_Fig1_HTML.png)
Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome | Scientific Reports
![LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study - Rathsman - 2021 - Journal of Internal Medicine - Wiley Online Library LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study - Rathsman - 2021 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1af5db12-2c49-496a-aad1-2731599e3612/joim13212-toc-0001-m.jpg)
LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study - Rathsman - 2021 - Journal of Internal Medicine - Wiley Online Library
![It really lowers LDL Cholesterol. How did it perform in a worldwide, 25,564 person research trial? | Windsor Dairy It really lowers LDL Cholesterol. How did it perform in a worldwide, 25,564 person research trial? | Windsor Dairy](https://windsordairy.com/wind/powerpoints/amgen/Slide14.jpg)
It really lowers LDL Cholesterol. How did it perform in a worldwide, 25,564 person research trial? | Windsor Dairy
![LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial - Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, Robert Giugliano, Terje R Pedersen, KyungAh Im, Huei LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial - Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, Robert Giugliano, Terje R Pedersen, KyungAh Im, Huei](https://journals.sagepub.com/cms/10.1177/2047487320902750/asset/images/large/10.1177_2047487320902750-fig1.jpeg)
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial - Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, Robert Giugliano, Terje R Pedersen, KyungAh Im, Huei
Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16Å Resolution at Physiological Body Temperature | PLOS ONE
![Table 3 from Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. | Semantic Scholar Table 3 from Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ef1033f8150845aef0d3a7a32b95aa1935115b5/5-Table3-1.png)
Table 3 from Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. | Semantic Scholar
![Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants - The Lancet Diabetes & Endocrinology Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/b635639f-3eba-4fe7-b8df-7a21f9f620a1/gr1.jpg)
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants - The Lancet Diabetes & Endocrinology
![Low-Density Lipoprotein (LDL) Cholesterol Levels over Time. Shown are... | Download Scientific Diagram Low-Density Lipoprotein (LDL) Cholesterol Levels over Time. Shown are... | Download Scientific Diagram](https://www.researchgate.net/publication/315890984/figure/fig1/AS:481840889896961@1491891228481/Low-Density-Lipoprotein-LDL-Cholesterol-Levels-over-Time-Shown-are-median-values-in.png)
Low-Density Lipoprotein (LDL) Cholesterol Levels over Time. Shown are... | Download Scientific Diagram
![Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins | Arteriosclerosis, Thrombosis, and Vascular Biology Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/56107c87-401c-4838-9164-ac835f595d51/atvbaha.120.315766.fig07.jpg)
Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins | Arteriosclerosis, Thrombosis, and Vascular Biology
![Can LDL cholesterol be too low? Possible risks of extremely low levels - Olsson - 2017 - Journal of Internal Medicine - Wiley Online Library Can LDL cholesterol be too low? Possible risks of extremely low levels - Olsson - 2017 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dade1b24-36dd-4145-9608-ae5d6abb7c8e/joim12614-fig-0002-m.jpg)
Can LDL cholesterol be too low? Possible risks of extremely low levels - Olsson - 2017 - Journal of Internal Medicine - Wiley Online Library
![Longitudinal associations between lymphocyte count and LDL cholesterol in a health screening population☆ | Semantic Scholar Longitudinal associations between lymphocyte count and LDL cholesterol in a health screening population☆ | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0536887698be047f6279bbba22da006d99224d15/3-Table3-1.png)
Longitudinal associations between lymphocyte count and LDL cholesterol in a health screening population☆ | Semantic Scholar
![Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease - ScienceDirect Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720345344-fx1.jpg)
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease - ScienceDirect
![Frontiers | Case Report: Hypercholesterolemia “Lean Mass Hyper-Responder” Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet Frontiers | Case Report: Hypercholesterolemia “Lean Mass Hyper-Responder” Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet](https://www.frontiersin.org/files/Articles/830325/fendo-13-830325-HTML-r1/image_m/fendo-13-830325-g004.jpg)
Frontiers | Case Report: Hypercholesterolemia “Lean Mass Hyper-Responder” Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet
![Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials - ScienceDirect Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109716372114-fx1.jpg)